Insurance or private practice: what changes in psychiatric care

A decision many patients need to make before starting psychiatric treatment — and one that is rarely discussed clearly — is between insurance-covered care and private-pay care. From the standpoint of immediate access, it looks like an obvious choice: insurance costs less, is already paid through the monthly premium, and offers a network of professionals available. From the standpoint of treatment quality, the choice is more complex than it appears, and it is worth understanding why.

This text is not intended to say that private care is always better. It is not. In many clinical situations, insurance-covered care, well indicated, resolves the case without any need to seek another path. But there are cases in which the structure of insurance-covered care, for reasons that have more to do with system rules than with the professional’s competence, makes certain kinds of treatment unfeasible. Recognizing which cases these are prevents frustration and prevents the patient from leaving the insurance experience thinking that “psychiatry does not work for me.”

The structural difference between the two models

The main difference between insurance-covered and private care is consultation time. A psychiatric appointment under insurance usually lasts between fifteen and thirty minutes, depending on the plan and the office. A serious private consultation usually lasts between sixty and ninety minutes, with first appointments commonly extending further — between ninety minutes and two hours.

That difference is not preciousness. It changes what can be done in the office. In fifteen minutes, you can review a prescription, adjust a dose, ask how the patient is feeling, reinforce guidance, schedule a follow-up. You cannot investigate life history in depth, cannot read the patient beyond what they say, cannot work on the therapeutic alliance, cannot conduct psychotherapy integrated with pharmacological management. It is a maintenance appointment, functional for stabilized cases in simple treatment. It is not an appointment for diagnostic investigation or for dense treatment.

The second difference is continuity. In many insurance networks, the patient does not have guaranteed continuity with the same psychiatrist over time — the professional may leave the network, the plan may reconfigure the roster, the office may change its policy for scheduling. This intermittency is bad for treatment that requires longitudinal reading of the case. In private practice, continuity is the default: the same psychiatrist follows the same patient throughout the process.

When insurance-covered care is enough

There is a range of scenarios in which insurance-covered care functions well and does not require the additional cost of private care. It is worth naming them so that the decision is based on real criteria, not marketing.

Uncomplicated maintenance of stabilized clinical pictures — patients on an already established medication scheme, with a defined diagnosis, without significant recent decompensations — fits well within the fifteen-minute-appointment format. Reviewing dose, reinforcing adherence, scheduling follow-up: this can be done well in that time.

Mild first depressive episodes in patients without significant psychiatric history often respond to a straightforward SSRI treatment that a competent insurance psychiatrist can conduct without loss. Isolated anxiety cases, without complex comorbidity, also fit.

Patients who value quick access and who understand that pharmacological management and psychotherapy will follow separate paths — psychiatrist for one, private psychologist for the other — may benefit from this configuration.

In these scenarios, insisting on private care is spending more without proportional clinical gain. Well-chosen insurance, with a competent professional, resolves the case.

When insurance-covered care will not suffice

There are scenarios in which the configuration of insurance-covered care makes adequate treatment technically unfeasible. Recognizing them helps avoid frustration.

Cases that require careful diagnostic investigation — suspected bipolarity, complex chronic anxiety pictures, personality disorders, mixed pictures with multiple comorbidities — do not fit into twenty-minute appointments. The investigation demands time, application of standardized instruments, clinical listening that needs space. Done in fragments across several short appointments, that investigation loses quality. Patients who need this are the same ones who usually leave insurance-covered treatment with an imprecise diagnosis and suboptimal management.

Cases that benefit from psychotherapy conducted by the psychiatrist themselves, with formal training in psychotherapy, are poorly served by insurance. This is a specific model — pharmacological care integrated with a psychotherapeutic process conducted by the same professional — that requires a setting and consultation time that insurance-covered care does not offer.

Patients who are physicians, lawyers, executives, or in similar positions of high responsibility often need refined pharmacological management, with careful choice of molecule to preserve cognitive function. That refinement also demands consultation time that insurance does not offer.

Patients who value deep confidentiality — the assurance that clinical information will not travel through the health-insurance operator, through a shared informatic system, through management audits — often prefer private care for legitimate reasons. Insurance, by nature, has mandatory information flow through the system. Private care offers stricter containment, with records under the direct control of the physician.

Patients whose treatment has dragged on without response to two or three previous attempts usually need a deeper investigation than insurance can offer. Staying another year in brief care, waiting for a response that does not come, is a high price that a dense private evaluation usually shortens.

What to consider in the decision

The choice between the two models should be made based on three criteria, and not on immediate cost alone.

The first is the kind of treatment the case requires. If it is simple maintenance follow-up, insurance serves. If it is complex diagnostic investigation or dense treatment, private care tends to deliver more.

The second is the value of the patient’s own time. A professional in a position of high responsibility, whose time lost in suboptimal treatment costs more than the financial difference between insurance and private care, faces a different equation from a patient with more flexibility in scheduling and less pressure on cognitive performance.

The third is the possibility of reimbursement. Many private plans offer partial reimbursement of private-consultation fees, and depending on the contract, a significant portion of the private fee may be returned. That reduces the real cost difference between the models, and it is worth investigating before assuming private care is out of reach.

What to ask before deciding

Before choosing between the two paths, a few questions help orient the decision. What is the real complexity of the case I am bringing — is it a simple first episode, or does it have a long history of previous attempts? How much time can I afford to wait for a response, considering the demands of my life? Does my plan offer significant reimbursement for private consultations? Does the ratio between cost and expected clinical gain justify private care for my specific case?

Made with honesty, this reflection usually makes the decision clear. And, made with these criteria, it produces much less frustration than a decision based on immediate cost alone.

What is gained by choosing the right model for one’s own case is time, direction, and treatment quality. What is lost by choosing wrong is months of suboptimal treatment that could have been avoided. That is the calculation worth making before scheduling the first appointment.

Dr. Leonardo Sodré is a medical psychiatrist in Brasília (CRM-DF 14,206 · RQE 14,761), with formal training and interest in psychoanalysis. This content is informational and educational, and does not replace individual clinical evaluation, diagnosis, or treatment.